Search Orphan Drug Designations and Approvals
-
| Generic Name: | a small molecule dual inhibitor of the enzymes LDHA and LDHB. LDH catalyzes the last committed step in the synthesis of oxalate. |
|---|---|
| Date Designated: | 08/21/2024 |
| Orphan Designation: | treatment of primary hyperoxaluria |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
Meta Pharmaceuticals (HK) Ltd Unit 505, 5/F, Biotech Centre 1 No. 9 Science Park West Avenue, Hong Kong Science Park Hong Kong, Special Administrative Region 999077 Hong Kong The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







